Alembic Pharmaceuticals Limited (BOM:533573)
India flag India · Delayed Price · Currency is INR
768.85
-19.95 (-2.53%)
At close: Feb 13, 2026

Alembic Pharmaceuticals Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Market Capitalization
151,334182,755193,57597,564145,771189,674
Market Cap Growth
-17.97%-5.59%98.41%-33.07%-23.15%88.33%
Enterprise Value
164,758192,124200,785104,548151,109193,139
Last Close Price
768.85919.07960.73479.74706.21906.13
PE Ratio
24.0631.3331.4328.5327.9816.54
PS Ratio
2.082.743.111.732.753.52
PB Ratio
2.853.524.022.232.783.74
P/TBV Ratio
2.973.524.022.232.874.00
P/FCF Ratio
--40.6934.78115.0423.60
P/OCF Ratio
-207.7524.1013.4826.3912.96
EV/Sales Ratio
2.272.883.221.852.853.58
EV/EBITDA Ratio
14.3919.4221.9715.0217.6013.17
EV/EBIT Ratio
19.1126.3330.3923.8825.7214.89
EV/FCF Ratio
--42.2137.27119.2624.03
Debt / Equity Ratio
0.280.240.110.170.140.12
Debt / EBITDA Ratio
1.301.250.551.010.820.39
Debt / FCF Ratio
--1.082.575.660.73
Net Debt / Equity Ratio
0.250.230.080.150.130.06
Net Debt / EBITDA Ratio
1.191.190.430.930.760.20
Net Debt / FCF Ratio
--2.470.832.315.180.37
Asset Turnover
-0.940.990.850.770.85
Inventory Turnover
-0.961.151.150.971.00
Quick Ratio
-0.620.820.740.520.51
Current Ratio
-1.702.121.781.672.07
Return on Equity (ROE)
-11.63%13.40%7.12%10.11%27.77%
Return on Assets (ROA)
-6.42%6.54%4.11%5.31%12.77%
Return on Invested Capital (ROIC)
10.58%10.38%12.59%7.74%8.69%20.59%
Return on Capital Employed (ROCE)
-13.60%13.20%9.60%10.90%23.90%
Earnings Yield
4.16%3.19%3.18%3.50%3.57%6.04%
FCF Yield
--2.60%2.46%2.88%0.87%4.24%
Dividend Yield
1.38%1.20%1.15%1.67%1.42%1.54%
Payout Ratio
-37.06%25.54%57.48%52.83%-
Buyback Yield / Dilution
0.41%----1.46%-2.77%
Total Shareholder Return
1.79%1.20%1.15%1.67%-0.04%-1.23%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.